Tracking and studying shifts in the market is crucial for understanding and predicting trends. This panel explores methodologies and insights for monitoring these changes and their broader implications to ensure all points in the design and supply chain remain vigilant.
Register Free: https://www.pharmtech.com/pt_w/market-shifts
Event Overview:
Tracking and studying shifts in the market is crucial for understanding and predicting trends, especially as the drug product pipeline evolves from clinical to commercial stages, encompassing new molecules and extensions of existing products. This panel discussion explores methodologies and insights for monitoring these changes and their broader implications to ensure all points in the design and supply chain remain vigilant. As forecasts adapt, the impact on various market outliers, including equipment and commodity suppliers, becomes significant. Suppliers must adjust their products to new configurations of evolving technologies that accommodate both higher-volume demands for blockbuster products and lower-volume needs for advanced therapy medicinal products.
Other market influences, such as the competitive landscape of the biosimilar market, the increase in emerging biopharma companies, and the rise in CDMO partnering, are shaped by various strategic and unpredictable elements. Quite simply, nobody can accurately predict market shifts for medicine demands. This session aims to highlight these dynamics through the lens of 4 pharma business segments: engineering firm, OEM, pharma supplier, and CDMO, particularly focusing on how companies can identify the differences in leading and lagging indicators that are readily available and can be used for developing marketing, manufacturing, supply, and overall growth strategies.
Key Learning Objectives:
- Understand how to look for market shifts, identify the difference between leading and lagging indicators, and apply insights from each business segment: engineering firm, OEM, pharma supplier, and CDMO, to several areas of focus.
- Understand what leading and lagging indicators to look for within segments and how to interpret the same market data in different ways that can be used for developing marketing, manufacturing, and supply strategies.
- Learn about the interconnectedness of our business segments, as well as where there are broad synergies that can be used to better partner with other pharma business segments to move the future of pharma ahead together.
Who Should Attend:
- CEOs and COOs
- Business development, strategy, and marketing personnel
- Product management, supply chain, manufacturing, and finance staff
- Packaging and engineering personnel
- Scientists and professionals in chemistry, manufacturing, and controls (CMC) and R&D
- Project management, regulatory, and quality professionals
Speakers:
Laura Englander
Senior Director, Market and Competitive Intelligence
West Pharmaceutical Services
Laura Englander, senior director of market and competitive intelligence at West Pharmaceutical Services, has over 25 years of invaluable experience within the life sciences industry, encompassing roles in medical devices, CDMOs, and pharmaceuticals. With a robust focus on sales and marketing leadership, Englander has consistently demonstrated her expertise in navigating complex market dynamics and driving growth. In her current role, Englander leads a dedicated team at West that is responsible for delivering critical insights into markets, the industry development pipeline, and competitors. Her team is adept at foreseeing disruptions, identifying emerging technologies and adjacencies, and understanding the potential business impact of these factors. Englander’s comprehensive understanding and forward-thinking approach make her a key contributor to ensuring West stays ahead in a competitive and ever-changing landscape.
Shannah Falcone
Vice President, Market Engagement Team
CRB
Shannah Falcone serves as CRB’s vice president, market engagement team. With over 20 years of experience, Falcone leads her team of both business and technical professionals to proactively align CRB’s solutions to meet the needs of clients, with a continuous focus on future market trends and opportunities. Falcone, a senior associate, is currently serving her second term on CRB’s board of directors. She has held numerous leadership positions within the International Society for Pharmaceutical Engineering and participates in the Strategic Account Management Association and Lean Construction Institute.
Michael Hennessy
Head of Global Sales
ProSys
Michael Hennessy is head of global sales at ProSys, a manufacturer of isolator and sampling technology for the biopharmaceutical market. A business graduate of the University of Limerick in Ireland, Hennessy has spent over 20 years serving the pharma sector in the provision of both equipment and contracting services. In his role, he also has a broad geographic responsibility, covering North America, Europe, and Southeast Asia. Aside from his primary role in sales, Hennessy also works very closely with R&D and product innovation colleagues at ProSys to optimize and develop existing and new equipment technologies to best serve the changing dynamics within the biopharma manufacturing landscape, whether that be related to cell and gene therapy scale-up; small batch and “personalized” fill/finish; or antibody-drug conjugate–based modalities.
Brad Wynja
Vice President, Business Development
INCOG BioPharma Services, Inc
Serving as VP of Business Development, Brad Wynja brings 20+ years of extensive and diverse life sciences industry experience to the leadership team at INCOG BioPharma. Prior to joining INCOG, Brad served as the Chief Financial Officer at Exelead, where he led the finance, business development, supply chain, project management, and IT organizations. Brad directed the acquisition of Exelead by Merk KGaA and its U.S. subsidiary MiliporeSigma in 2022. Prior to that, he held senior leadership roles in finance at Catalent and Covance/LabCorp.
Brad holds an MBA from Drake University, and he completed his undergraduate work in Accounting and Finance at the Central University of Iowa. He is also a member of the American Institute of Certified Public Accountants.
Moderator
Christa Myers
Senior Fellow, Aseptic and Sterile Products
CRB
Christa Myers is a business leader and subject-matter expert in aseptic and sterile products equipment, processes, and facilities. Her career includes work as a process chemical engineer, facility planner, and business strategist, spanning more than 30 years of experience. Her knowledge of the regulatory environment provides clients with insight on how codes; past and current regulations; and innovative technologies apply to their process and facility designs.
Register Free: https://www.pharmtech.com/pt_w/market-shifts
